Keros Therapeutics (KROS) SEC Filings & 10K Form

$56.40

+1.65 (+3.01%)

(As of 09/12/2024 ET)

Compare

Recent Keros Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
09/03/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/28/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/15/2024 4:06 PM	GORDON CARL L (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/15/2024 4:01 PM	Keros Therapeutics (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/13/2024 3:12 PM	Keros Therapeutics (Subject) ORBIMED ADVISORS LLC (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/07/2024 3:02 PM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/17/2024 4:15 PM	Keros Therapeutics (Filer)	Form 424B5
Get the Latest News and Ratings for KROS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
06/17/2024 4:17 PM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/17/2024 5:07 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/05/2024 3:10 PM	BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)	Form 3 Initial statement of beneficial ownership of securities
06/05/2024 3:11 PM	BIENAIME JEAN JACQUES (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/04/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/03/2024 3:15 PM	Farzan Nima (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	GORDON CARL L (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	GRAY MARY ANN (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	Keros Therapeutics (Issuer) Knowles Julius (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	Keros Therapeutics (Issuer) Nussbaum Ran (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	Kariv Tomer (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 3:15 PM	Keros Therapeutics (Issuer) Seth Alpna (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/03/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/08/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/08/2024 7:03 AM	Keros Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/03/2024 7:00 AM	Keros Therapeutics (Filer)	Form S-3ASR
03/14/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/06/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/05/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/05/2024 7:02 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/28/2024 3:02 PM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/15/2024 7:37 PM	Cooper Simon Peter (Reporting) Keros Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 7:38 PM	Keros Therapeutics (Issuer) Rovaldi Christopher (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 7:40 PM	Keros Therapeutics (Issuer) Regnante Keith (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 7:41 PM	Keros Therapeutics (Issuer) Seehra Jasbir (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 5:38 PM	ALKEON CAPITAL MANAGEMENT LLC (Filed by) Keros Therapeutics (Subject)	Form SC 13G/A
02/09/2024 8:16 AM	FMR LLC (Filed by) Keros Therapeutics (Subject)	Form SC 13G/A
01/26/2024 4:26 PM	BlackRock Inc. (Filed by) Keros Therapeutics (Subject)	Form SC 13G/A
01/09/2024 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/08/2024 3:43 PM	Keros Therapeutics (Issuer) Regnante Keith (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
01/04/2024 3:02 PM	Keros Therapeutics (Filer)	Form 424B5
01/04/2024 3:04 PM	Keros Therapeutics (Subject) Regnante Keith (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
01/04/2024 3:04 PM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/03/2024 7:04 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
“Why I don’t care if the Fed cuts rates” - SYKES (Ad) In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weekend Trading. It’s the best strategy I know of - because it revolves around making a quick trade right before the market closes on Friday afternoon… And closing the trade when the market opens the following Monday. I’m hosting a free trading broadcast on Thursday, September 12 at 6 PM ET to show you exactly how y
12/13/2023 4:20 PM	Keros Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)	Form SC 13D/A
12/11/2023 5:44 PM	Keros Therapeutics (Subject) ORBIMED CAPITAL LLC (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
12/11/2023 5:02 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/07/2023 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/06/2023 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/06/2023 7:06 AM	Keros Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
11/06/2023 7:11 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
10/04/2023 7:01 AM	Keros Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)